Egyptian Journal of Medical Human Genetics

Table 1 Serum ER level (ng/ml) and E2 level (pg/ml) in AML and ALL male/female patients and control group

From: Serum estrogen and its soluble receptor levels in Egyptian patients with acute leukemia: case-control study

	Control (n = 20)	AML (n = 20)	ALL (n = 20)
ER (ng/ml) in male
Range	1.17–9.27	0.36–14.11	0.30–2.47
Mean ± SE	5.67 ± 0.81	1.91 ± 0.75	1.24 ± 0.26
Median	5.08	0.75	0.98
H(p)	15.485(< 0.001)
p₁	< 0.001*
p₂	0.002*
p₃	0.915
ER (ng/ml) in female
Range	0.72–7.75	0.51–11.30	0.24–1.67
Mean ± SE	5.29 ± 0.81	2.37 ± 1.09	0.94 ± 0.11
Median	5.66	0.96	0.94
H(p)	10.278(0.006)
p₁	0.012*
p₂	0.003*
p₃	0.629
E2 (pg/ml) in male
Range	10.80–44.10	2.70–69.80	3.20–33.40
Mean ± SE	29.96 ± 3.12	15.07 ± 3.90	12.52 ± 3.64
Median	31.80	8.61	10.10
H(p)	11.713(0.003)
p₁	0.001*
p₂	0.005*
p₃	0.920
E2 (pg/mL) in female
Range	2.90–154.0	2.50–16.70	2.80–20.80
Mean ± SE	51.99 ± 17.48	5.70 ± 1.41	8.80 ± 1.60
Median	35.10	4.05	7.70
H(p)	9.456(0.009)
p₁	0.009*
p₂	0.041*
p₃	0.059

H, p, H and p values for Kruskal-Wallis test. Pairwise comparison bet. each of the 2 groups was done using post hoc test (Dunn’s for multiple comparisons test). p₁, p value for comparing between control group and AML group; p₂, p value for comparing between control group and ALL group; and p₃, p value for comparing between AML group and ALL group
*Statistically significant at p ≤ 0.05

Back to article page